Umeclidinium
CAS 869185-19-3Small Molecule
Overview
Umeclidinium is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1187833).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Umeclidinium expires 18 Dec 2027. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanol
- Canonical SMILES
- C1C[N+]2(CCC1(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)CCOCC5=CC=CC=C5
- InChIKey
- FVTWTVQXNAJTQP-UHFFFAOYSA-N
Verified Supplier Partner
Do you supply Umeclidinium? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.